A43.0

Clinical Causes: Infection with Nocardia bacteria, which are typically found in soil, decaying organic matter, and water. Transmission occurs through inhalation of airborne bacteria or, less commonly, through skin wounds contaminated with Nocardia. Individuals with compromised immune systems, such as those with HIV/AIDS, cancer, diabetes, or on immunosuppressive therapy, are at higher risk. Pre-existing lung conditions like chronic obstructive pulmonary disease (COPD) can increase susceptibility.

Key Symptoms: Persistent cough that may produce sputum, sometimes bloody. Fever and chills, often prominent during the early stages. Chest pain or discomfort, especially during breathing or coughing. Unintended weight loss and fatigue. Shortness of breath or difficulty breathing. Night sweats and malaise. In some cases, symptoms can resemble tuberculosis or other lung infections.

Diagnosis Path: Chest X-ray or CT scan to identify lung abnormalities such as infiltrates or nodules. Sputum or tissue sample analysis under a microscope to detect Nocardia bacteria, which may show branching filamentous structures. Culture of respiratory samples to confirm Nocardia species, although it requires patience due to slow bacterial growth. Molecular techniques like PCR for precise identification. Assessment of immune function to determine underlying vulnerabilities.

Treatment Protocols: Administration of antibiotics such as trimethoprim-sulfamethoxazole as the first-line treatment. Alternative antibiotics like amikacin, linezolid, or minocycline may be used depending on case severity and species identification. Prolonged treatment duration, often spanning 6 to 12 months, to ensure complete eradication. Supportive care addressing symptoms and complications. Managing underlying health conditions and improving immune system function.